Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2854-2026

Brand Name: WASPLab Product Name: WASPLab Recall

Brand Name: WASPLab Product Name: WASPLab Model/Catalog Number: W087 Software Version: WebApp version 2.33.1, 2.33.3 and 2.34.2 Product Description: WASPLab is an automated device intended to be used for the incubation and the digital imaging of agar culture plates streaked with microbiological specimens derived by the human body for microbiological investigations. WebApp software is the user interface of WASPLab device.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: WASPLab Product Name: WASPLab. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2854-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 16, 2026
FDA report date
Aug 12, 2026
Quantity in commerce
1
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brand Name: WASPLab Product Name: WASPLab Model/Catalog Number: W087 Software Version: WebApp version 2.33.1, 2.33.3 and 2.34.2 Product Description: WASPLab is an automated device intended to be used for the incubation and the digital imaging of agar culture plates streaked with microbiological specimens derived by the human body for microbiological investigations. WebApp software is the user interface of WASPLab device.

Affected model & UDI checker

Search the exact identifiers published for Z-2854-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
W087Brand Name: WASPLab Product Name: WASPLabCheck source noticeNot specified
FDA code information

Lot Code: WebApp version 2.33.1, 2.33.3 and 2.34.2

View the original FDA recall notice

Why was this product recalled?

Due to a software issue within the WebApp that potentially prevents the user to overwrite the results.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Copan WASP take?

On 06/16/2026, an "URGENT MEDICAL DEVICE RECALL" Letter was provided to customers informing them that, A software bug has been identified in the WebApp software which, under specific conditions, may prevent the result suggested by PhenoMATRIX from being overwritten by the result selected by the user. As a consequence, the result transmitted by WASPLab to the LIS may be the result suggested by PhenoMATRIX, rather than the result selected by the user. Customers were informed and instructed: In date 2026/06/15 we released a WebApp software version including the bugfix of this issue. As a consequence, you are required to schedule with your distributor the software update to correct the issue and, in the meanwhile, to check the results sent to LIS in case you changed the result suggested by PhenoMATRIX. Complete the attached Customer Response Form and return to the Copan WASP Srl contact noted on the form so that Copan WASP Srl may acknowledge your receipt of this notification. For questions or further assistance email [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology